Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.272EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.371EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.353EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.353EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.407EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.407EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.254EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.254EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.39.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.418EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.122EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.122EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.11.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used